China SFDA Moves Botulinum Toxin Type A Under Toxic Drug Category
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's Ministry of Health and State FDA have moved neurotoxin Botox (botulinum toxin type A) under toxic drug control, the two institutions declared in a joint notice July 22